🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to have our collaborative research on GB13 as a #DMG treatment shared by Julian Rechberger #SNOPeds #DIPG

Grateful to the W. W. Smith Trust for funding our project, which will further strengthen our ability to leverage liquid biopsy in identifying candidates for clinical trials and for disease monitoring. Excited for our collaboration with Targepeutics. Penn State Neurosurgery #Glioblastoma

We want to thank Dr. Giselle Sholler Giselle Sholler and the entire Beat Childhood Cancer team for giving us this opportunity to talk about GB13, our promising lead therapeutic for #DIPG #DMG.

Targepeutics Giselle Sholler Beat Childhood Cancer Fantastic work Targepeutics . Looking forward to bringing GB13 into clinical trials! #glioblastoma #DIPG #RareDiseaseDay EndBrainCancer Initiative OurBrainBank National Brain Tumor Society Brain Tumour Research WeTrials

A great Beat Childhood Cancer annual meeting. Grateful to Dr Sholler, BCC and Four Diamonds for the continued support! #DIPG #DMG

Words can’t express the gratitude to Tough2gether - Against DIPG and DDRFA and the continued support of our upcoming #DIPG #DMG trial with GB13. #behindtheribbon

End Wokeness Don’t forget to celebrate diversity!

🚨 Big news! We’re welcoming the Yuvaan Tiwari Foundation Foundation as a new strategic partner in our fight against #DIPG. Their investment advances GB13 into clinical trials. Together, we’re fighting one of the deadliest pediatric brain cancers with bold science and deep purpose.#DMG

IL13Ra2 is overexpressed on brain cancer; we have drugs that target the receptor and are ready NOW, but no $ to finish. HELP #CancerMoonshot